068270.KS

Potentially Overvalued

Celltrion, Inc. — PEG Ratio Analysis

6.38

PEG Ratio

6.38

Growth Rate Source

Good Data Quality5-Year EPS CAGR

Current Price

$161100.00

TTM EPS

$5580.59

P/E Ratio

28.87

Growth Rate

4.5%

5-Year EPS CAGR

Sector

Healthcare

Biotechnology

Calculated

6/17/2026

9:23:07 AM

Peer Comparison

Sample Size

5 peers

Industry Median PEG

1.57

25th Percentile

0.56

75th Percentile

1.67

068270.KS PEG (6.38) vs Industry Median (1.57): 305% premium

Symbol	Company	PEG	P/E	Growth	vs 068270.KS
005380.KS	Hyundai Motor Company	0.50	18.8	37.4%	-92%
207940.KS	Samsung Biologics Co.,Ltd.	0.56	33.8	60.7%	-91%
035420.KS	NAVER Corporation	1.57	21.4	13.6%	-75%
035720.KS	Kakao Corp.	1.67	40.2	24.1%	-74%
326030.KS	SK Biopharmaceuticals Co., Ltd.	1.88	21.0	11.1%	-71%

How to Interpret PEG Ratio

PEG < 1.0 — Potentially Undervalued. The stock may be priced below its earnings growth rate, suggesting a potential buying opportunity.

PEG 1.0–2.0 — Fairly Valued. The stock price is roughly in line with its earnings growth. A PEG of 1.0 is often considered "fair value."

PEG > 2.0 — Potentially Overvalued. The stock may be priced above what its earnings growth justifies.

Limitations:PEG ratios are less reliable for financial firms (earnings driven by interest margins), companies with negative/zero earnings growth, and hypergrowth companies (>100% growth) where the ratio may appear misleadingly low. Always use PEG alongside other valuation metrics.